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Abstract 
Introduction: Salivary biomarkers may elucidate orodental inflammatory processes. Nitric oxide 
(NO) may help us to diagnose such changes. 
Methods: In this case-control study, all referral patients diagnosed with 1<clinical attachment loss 
(CAL) ≤4mm in >30% sites were enrolled as generalized mild to moderate periodontitis group 
(PG). All PG and healthy control group (CG)’ individuals underwent scaling and root planning 
(SRP). The periodontal indices were recorded at baseline (day0) in both PG and CG, in addition to 
14 days after SRP (day 14) : salivary nitric oxide level on same occasions also recorded. 
Results: Twenty seven individuals were enrolled as PG and 17 individuals were assessed in CG. 
All indices were improved with SRP after 14 days. Except for NO, none of the periodontal indices 
subsided to the normal values of CG. 
Conclusions: Nitric oxide is a sensitive biomarker in tracing periodontal inflammation. 
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Introduction 
Currently, saliva received high attention as a sole or 
adjunct diagnostic tool in the field of dentistry (1). 
Nitric oxide (NO) is available by either entero-
circulatory-salivary circulation or NO synthase (NOS) 
in mammalians. The latter consists of three main 
isoforms; e-NOS (NOS3), n-NOS (NOS1) and i-NOS 
(NOS2). 
 Nitric Oxide Synthase 1,3 are constitutional and 
calcium-enzymatic dependent forms that produce 
lesser amount that last shorter when compared to i-
NOS as an inducible form which its production is 
dependent onpro-inflammatory cytokines(e.g., IL1,  
 
 
TNFα, and IFNγ) with a destructive characteristic that 
is produced in a higher amount and greater durability 
(2). Nitric oxide participates in immune modulation 
(e.g., respiratory burst, neutrophil oxidative stress), 
decreases platelet aggregation, induces vasodilation 
and possesses anticariogenic, antibacterial and bone 
remodelling properties. The main sources of saliva may 
be addressed to nerve endings, secretory cells of 
salivary glands, salivary gland endothelial cells and 
oral bacteria products besides ingested nitrate and 
nitrites (3-5). We aimed to assess how salivary nitric 
oxide level reflects the success of scaling and root 
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planning (SRP) in patients with mild to moderate 
generalized chronic periodontitis. 
 
 
Methods 
An analytic cross-sectional study was designed and 
all referral patients diagnosed with clinical attachment 
loss (CAL)≤4mm and more than 1mm in>30% sites 
were enrolled as generalized mild to moderate periodontitis 
group (PG).  
The exclusion criteria were active oral lesions, oral 
cancers, salivary glands inflammation and infection, 
concurrent anti-inflammatory or antibiotic 
consumptions, cigarette smoking, prior SRP during last 
6 months and bleeding diathesis. For comparison, 
healthy individuals with <1 mm CAL were included as 
CG. All PG patients were candidate for non-surgical 
phase I periodontal therapy including oral hygiene 
instructions and SRP. Periodontal indices consisting of 
plaque index (PI), gingival index (GI), clinical 
attachment loss (CAL), bleeding index (BI) and 
probing pocket depth (PPD) were recorded at baseline 
(day0) in both PG and CG, in addition to 14 days after 
SRP (day14) in PG. Besides, un-stimulated saliva was 
obtained after 1-hour with no drinking and eating and 
NO content was measured with colorimetric Griess 
reaction at day 0,14 using a spectrophotometer calibrated 
at 540 nm. Comparisons were accomplished using 
paired and independent t-test. The significant level was 
two tailed α error<0.05. This research was approved by 
the Ethics Committee of Babol University of Medical 
Sciences. 
 
 
Results 
Twenty seven individuals were enrolled as PG and 
17 individuals were assessed in CG. Among those, 
there were10 (58.8%) females and 7 (41.2%) males in 
PG and 16(59.3%) females and 11(40.7%) males in 
CG. Gender distribution did not differ in groups 
(p<0.58). The detailed descriptive and analytic data are 
summarized in tables 1and 2. 
 
Table 1. Changing Trends of Inflammatory Indices in Periodontitis Group during the Study Course 
 
Index Before SRP
†
(SD)
††
 After SRP(SD) Effect Size(CI%95) Significance 
Probing Pocket Depth 2.84±0.41 2±0.27 0.84(0.59-1.08) t(15)=7.33,  p<0.001 
Plaque Index 1.69±0.28 0.57±0.33 1.12(0.92-1.32) t(15)=12.17, p<0.001 
Gingival Index 1.79±0.24 0.86±0.1 0.93( 0.82-1.04) t(15)=18.36, p<0.001 
Bleeding Index 1.69±0.33 0.9±0.13 0.72(0.57-0.82) t(15)=10.09, p<0.001 
Clinical Attachment Loss 2.91±0.37 2.33± 0.35 0.57(0.47- 0.68) t(15)=11.65, p<0.001 
Nitric Oxide 169±86 79±71 90(58-122) t(16)= 6.08, p<0.001 
  † SRP: Scaling and Root Planning †† SD: Standard Deviation 
 
Table 2. Comparison of Inflammatory Indices between control group (CG) and  
Periodontitis group (PG) 14 days after SRP 
 
Index CG
†
(SD)
††
 PG
†††
(after SRP
‡
) (SD) pvalue 
Nitric Oxide (mg) 63.47±7.84 79±71 0.4 
Probing Pocket Depth (mm) 1.16±0.13 2±0.27 <0.001 
Bleeding Index 0.16±0.06 0.9±0.13 <0.001 
Gingival Index 0.2 0.86±0.1 <0.001 
Plaque Index 0.33±0.02 0.57±0.33 <0.001 
                            † CG: Control Group, †† SD: Standard Deviation, †††PG: Patient Group, ‡SRP: Scaling and Root Planning 
 
Discussion 
Based on literature, our study is among the few 
studies that evaluate the diagnostic role of NO for the 
success of phase I periodontal therapy. A significantly  
 
 
lower salivary NO level was measured after SRP 
(effect size= 90 mg, p<0.001). More recent studies, 
argued and agreed upon this finding as well (6, 7). 
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Previously, Gullu et al. showed that SRP to a higher 
extent modified Widman Flap (MWF) surgery 
attenuated inflammation measured by i-NOS 
expression in gingival biopsies of chronic periodontitis 
patients (7). This was accompanied by rising arginase 
level that competes with NOS for arginine as the 
substrate of their pathways (8). On the contrary, 
Gheren et al. claimed that periodontal therapy may 
reduce arginase level in saliva of chronic periodontitis 
patients (9). E-NOS and n-NOS, to a lesser extent, 
regulate osteblastic function and enforce estrogen-
derived bone formation (8). 
Moreover, many studies clarified that i-NOS was 
related to gingival inflammation and bone destruction. 
Prostaglandins and bacterial LPS are responsible for 
gene up-regulation of i-NOS with subsequent 
osteoclastic differentiation, atherosclerosis and endothelial 
dysfunction  in addition to down regulation of e-NOS 
(5).  
Hence, pharmacologic suppression of i-NOS 
expression may clinically prevent further bone loss 
(e.g., Simvastatin, a lipid lowering agent, may inhibit 
Cyclosporine-A induced bone loss by lowering i-NOS 
expression (10). Newly introduced guided pocket re-
colonization (GPR) may also be helpful in treating 
periodontal disease. GPR is an implantation of bio-
friendly probiotics (e.g., Lactobacillus Brevis) within 
the depth of periodontal pocket, by which matrix 
metalloproteinase activity and i-NOS expression are 
diminished (11).  
As demonstrated in the tables, all indices decreased 
dramatically after SRP. Nevertheless, these indices 
were considerably higher than the baseline indices in 
the CG (p<0.001), except for the NO level (p=0.4). 
According to our findings, salivary NO may be 
more sensitive than clinical judgment of success of 
non-surgical periodontal therapy. Conclusively, 
salivary NO as a sensitive biomarker can also be 
applied when a dormant progressive inflammation in the 
course of periodontal diseases is suspected for the 
diagnostic and assessment of treatment purposes.  
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